Niramai Health Analytix develops an AI-based medical device called Thermalytix for early breast cancer detection. This non-invasive, radiation-free solution uses thermal imaging and machine learning to analyze temperature patterns, offering an affordable and accessible screening method for women of all ages. The company aims to improve breast cancer mortality rates through early diagnosis and has received regulatory clearances from the US FDA and European CE Mark.